The market session has come to an end, and the closing bell has rung... so now it is time to go through today's biggest movers to the upside. Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock winners in trading on Wednesday, October 4th.
22nd Century Group, Inc. (NYSE:XXII)
Shares of 22nd Century Group, Inc. rose 8.16% on higher than average trading volume, closing the day at $3.05 per share. A quick look at XXII options show an interesting trade opportunity.
Cannimed Therapeutics Inc. (OTC:CMMDF)
Shares of Cannimed Therapeutics Inc. rose 9.36% on higher than average daily trading volume, closing the day at $9.0933 per share.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
Shares of GW Pharmaceuticals Plc. rose 6.89% on higher than average daily trading volume, closing the day at $110.88 per share. A quick look at GWPH options show an interesting trade opportunity.
India Globalization Capital, Inc. (NYSE:IGC)
Shares of India Globalization Capital, Inc. advanced 6.47% on higher than average daily trading volume, closing the day at $0.4149 per share.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Shares of Therapix Biosciences Ltd. rose 6.15% today on higher than average trading volume, closing the day at $5.7957 per share.
Find more about today's gainers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.